BridgeMD
New treatment option for Adhesive Capsulitis of the Shoulder
Official title Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment
ClinicalTrials.gov ID: NCT07336849
What this study is testing
- What it's testing
- Evaluation of the efficacy and safety of transcatheter arterial embolization using 'Nexsphere-F' for pain relief in patients with adhesive capsulitis of the shoulder joint that does not respond to conservative treatment. This study aims to investigate the efficacy and safety of transcatheter arterial embolization using embolic agents in patients with adhesive capsulitis of the shoulder joint.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 85
You may be able to join if
- Patients who have voluntarily signed a written informed consent form after receiving an explanation of the purpose, methods, and potential effects of...
- Patients aged between 19 and 85 years
- Patients with pain persisting for more than 3 months in the affected area and with a history of receiving physical therapy...
- Patients with a measured shoulder joint range of motion (ROM) of less than 90 degrees ⑤ Patients who agree not to receive any conservative treatment...
- Patients who are willing to comply with the treatment and procedures of the clinical trial and participate in all follow-up evaluations through...
You likely can't join if
- Patients with a history of surgery on the shoulder joint targeted for the clinical trial prior to screening
- Patients suspected of having a full-thickness rotator cuff tear
- Patients with bleeding disorders or coagulopathies (e.g., idiopathic thrombocytopenic purpura, hemophilia, disseminated intravascular coagulation)
- Patients with advanced atherosclerosis or vasospasm in the arm vessels, or those expected to have such conditions
- Patients with a known hypersensitivity to gelatin ⑥ Patients with a known hypersensitivity to contrast media ⑦ Patients who are pregnant or...
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.